Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	76,577	68,142	103,130	102,836	137,287	220,012
Market Cap Growth	3.37%	-33.93%	0.29%	-25.09%	-37.60%	69.27%
Enterprise Value	76,406	64,237	96,968	93,065	120,665	201,284
Last Close Price	5220.00	4645.00	7030.00	7010.00	9410.00	15200.00
PS Ratio	3.48	3.47	5.94	6.42	9.63	16.86
PB Ratio	2.98	2.49	4.10	3.55	4.43	6.51
P/TBV Ratio	3.01	2.52	4.15	3.58	4.47	6.57
EV/Sales Ratio	3.48	3.27	5.58	5.81	8.46	15.43
EV/FCF Ratio	-19.26	-	-	-	-	-
Debt / Equity Ratio	0.41	0.40	0.40	0.27	0.19	0.13
Asset Turnover	0.54	0.48	0.43	0.39	0.35	0.31
Inventory Turnover	9.65	11.20	10.90	11.41	11.87	13.72
Quick Ratio	1.01	1.23	1.49	2.02	2.97	4.20
Current Ratio	1.29	1.47	1.77	2.33	3.30	4.65
Return on Equity (ROE)	-9.71%	-8.98%	-9.00%	-6.82%	-9.52%	-6.78%
Return on Assets (ROA)	-3.59%	-3.71%	-4.09%	-3.32%	-6.83%	-5.20%
Return on Capital (ROIC)	-4.13%	-4.17%	-4.57%	-3.71%	-7.49%	-5.58%
Return on Capital Employed (ROCE)	-8.00%	-8.00%	-9.50%	-6.90%	-13.50%	-9.60%
Earnings Yield	-3.11%	-3.46%	-2.36%	-1.99%	-2.24%	-1.07%
FCF Yield	-5.18%	-3.34%	-3.29%	-6.78%	-1.96%	-1.14%
Buyback Yield / Dilution	-0.13%	0.06%	-0.51%	-0.54%	-0.66%	-1.30%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.